Skip to search formSkip to main contentSkip to account menu

Protein Kinase C Inhibitor LXS196

Known as: LXS196, PKC Inhibitor LXS196 
An orally available protein kinase C (PKC) inhibitor with potential immunosuppressive and antineoplastic activities. Upon oral administration… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
We assessed the safety, tolerability, PK, PD and efficacy of the PKC inhibitor LXS196 in patients with metastatic uveal melanoma… 
2019
2019
Abstract Background Uveal melanoma (UM) is a rare cancer that arises from melanocytes in the uveal tract of the eye. Despite…